How ResMed, Inspire Medical Woke Up Demand for Innovative Apnea Devices & Data

09.17.2021 - By DeviceTalks

Download our free app to listen on your phone

Zoll Medical’s acquisition of Itamar Medical is just latest sign of the opportunity diagnosing and treating sleep apnea presents to medical device companies, especially following the CPAP machine recall issued by Philips Respironics earlier this summer.

This week, we’ll talk with two of the leaders in this increasingly competitive market.

First, we’ll reconnect with Tim Herbert, CEO of Inspire Medical Systems, to learn how that neurostimulation company is working to serve patients seeking an alternative to CPAP machines.

This is our second visit with Tim Herbert. You can find his earlier interview on DeviceTalks.com.

Then we welcome Michael “Mick” Farrell, CEO of ResMed, the leading provider of CPAP machines. Farrell explains why the apnea market is growing and what this means for the future of ResMed, which has grown into other respiratory businesses.

Chris Newmarker returns! The executive editor of life sciences at MassDevice presents his Newmarker’s Newsmakers including Zoll, Itamar, Medtronic, Medicrea, iRhythm, Zimmer and its new spinout, ZimVie.

We also discuss CMS’s disappointing backtrack on reimbursing innovative technologies.

Danielle Kirsh, senior editor of life sciences, also presents a short report on the trial of Theranos founder Elizabeth Holmes.

More episodes from DeviceTalks